(Q37974674)

26 August 2017

title

Current status of molecular markers for prognostication and outcome in invasive bladder cancer (English)

1 reference

26 August 2017

Georgios Gakis

1

1 reference

26 August 2017

Christian Schwentner

series ordinal

2

1 reference

26 August 2017

Tilman Todenhöfer

series ordinal

3

1 reference

26 August 2017

Arnulf Stenzl

series ordinal

4

1 reference

26 August 2017

publication date

11 January 2012

1 reference

26 August 2017

1 reference

26 August 2017

volume

110

1 reference

26 August 2017

issue

2

1 reference

26 August 2017

page(s)

233-237

1 reference

Estrogen receptor and progesterone receptor as predictive biomarkers of response to endocrine therapy: a prospectively powered pathology study in the Tamoxifen and Exemestane Adjuvant Multinational trial

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10839.X

Expression status and prognostic significance of mammalian target of rapamycin pathway members in urothelial carcinoma of urinary bladder after cystectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10839.X

Accumulation of nuclear p53 and tumor progression in bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10839.X

p53 gene and protein status: the role of p53 alterations in predicting outcome in patients with bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10839.X

Expression of cell cycle-related molecular markers in patients treated with radical cystectomy for squamous cell carcinoma of the bladder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10839.X

Predictive value of combined immunohistochemical markers in patients with pT1 urothelial carcinoma at radical cystectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10839.X

p53, p21, pRB, and p16 expression predict clinical outcome in cystectomy with bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10839.X

Correlation of immunohistochemical molecular staging of bladder biopsies and radical cystectomy specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10839.X

Cooperative effect of cell-cycle regulators expression on bladder cancer development and biologic aggressiveness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10839.X

p53 and p21 Expression levels predict organ preservation and survival in invasive bladder carcinoma treated with a combined-modality approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10839.X

Combined effects of p53, p21, and pRb expression in the progression of bladder transitional cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10839.X

Expression of pRb, p53, p16 and cyclin D1 and their clinical implications in urothelial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10839.X

Multiple biomarkers improve prediction of bladder cancer recurrence and mortality in patients undergoing cystectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10839.X

Use of combined apoptosis biomarkers for prediction of bladder cancer recurrence and mortality after radical cystectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10839.X

Thrombospondin-1 expression in bladder cancer: association with p53 alterations, tumor angiogenesis, and tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10839.X

Statistical consideration for clinical biomarker research in bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10839.X

10.1111/J.1464-410X.2011.10839.X

21 January 2018

Identifiers

DOI

1 reference

26 August 2017

1 reference